Raymond J. Henley Iii

Array ( [id] => 1065705 [patent_doc_number] => 06846831 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-25 [patent_title] => 'Method of treating the syndrome of lipodystrophy' [patent_app_type] => utility [patent_app_number] => 10/179993 [patent_app_country] => US [patent_app_date] => 2002-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9445 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846831.pdf [firstpage_image] =>[orig_patent_app_number] => 10179993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1231581 [patent_doc_number] => 06693073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-17 [patent_title] => 'Pulmonary delivery of active agents' [patent_app_type] => B2 [patent_app_number] => 10/172582 [patent_app_country] => US [patent_app_date] => 2002-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 9480 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/693/06693073.pdf [firstpage_image] =>[orig_patent_app_number] => 10172582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367536 [patent_doc_number] => 20040006055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Neuroprotection and cardioprotection afforded by chelators with high affinity and specificity for cations of first transition series elements' [patent_app_type] => new [patent_app_number] => 10/172766 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15530 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006055.pdf [firstpage_image] =>[orig_patent_app_number] => 10172766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818224 [patent_doc_number] => 20030069182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Protein formulations' [patent_app_type] => new [patent_app_number] => 10/170301 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5951 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069182.pdf [firstpage_image] =>[orig_patent_app_number] => 10170301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6261904 [patent_doc_number] => 20020187967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol' [patent_app_type] => new [patent_app_number] => 10/166506 [patent_app_country] => US [patent_app_date] => 2002-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12154 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187967.pdf [firstpage_image] =>[orig_patent_app_number] => 10166506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034401 [patent_doc_number] => 20050032911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Methods for preventing and treating diseases and conditions associated with cellular stress' [patent_app_type] => utility [patent_app_number] => 10/479774 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2071 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032911.pdf [firstpage_image] =>[orig_patent_app_number] => 10479774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702263 [patent_doc_number] => 20030225143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Pharmaceutically acceptable salt of amlodipine and method of preparing the same' [patent_app_type] => new [patent_app_number] => 10/160154 [patent_app_country] => US [patent_app_date] => 2002-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1969 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225143.pdf [firstpage_image] =>[orig_patent_app_number] => 10160154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123928 [patent_doc_number] => 06794400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => '4-substituted-1-(arylmethylidene)thiosemicarbazide, 4-substituted-1-(arylcarbonyl)thiosemicarbazide and analogs as activators of caspases and inducers of apoptosis and the use thereof' [patent_app_type] => B2 [patent_app_number] => 10/158827 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21723 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794400.pdf [firstpage_image] =>[orig_patent_app_number] => 10158827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6258548 [patent_doc_number] => 20020187104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Calcuim phosphate delivery vehicles for osteoinductive proteins' [patent_app_type] => new [patent_app_number] => 10/160607 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9683 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187104.pdf [firstpage_image] =>[orig_patent_app_number] => 10160607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002491 [patent_doc_number] => 06908946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Conjugated nonadecadienoic acid compositions' [patent_app_type] => utility [patent_app_number] => 10/161476 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3756 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908946.pdf [firstpage_image] =>[orig_patent_app_number] => 10161476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6178850 [patent_doc_number] => 20020156293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-24 [patent_title] => 'Process for the preparation of zofenopril calcium salt' [patent_app_type] => new [patent_app_number] => 10/155129 [patent_app_country] => US [patent_app_date] => 2002-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2550 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20020156293.pdf [firstpage_image] =>[orig_patent_app_number] => 10155129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843443 [patent_doc_number] => 20020131954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Interleukin antagonists for the treatment of neurological, retinal and muscular disorders' [patent_app_type] => new [patent_app_number] => 10/152476 [patent_app_country] => US [patent_app_date] => 2002-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4989 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20020131954.pdf [firstpage_image] =>[orig_patent_app_number] => 10152476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 993736 [patent_doc_number] => 06916835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-12 [patent_title] => 'Nitrate esters and their use for neurological conditions' [patent_app_type] => utility [patent_app_number] => 10/147808 [patent_app_country] => US [patent_app_date] => 2002-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 18219 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/916/06916835.pdf [firstpage_image] =>[orig_patent_app_number] => 10147808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1589369 [patent_doc_number] => 06482828 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => '4-(4-hydroxyphenyl) amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer' [patent_app_type] => B1 [patent_app_number] => 10/145639 [patent_app_country] => US [patent_app_date] => 2002-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4204 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482828.pdf [firstpage_image] =>[orig_patent_app_number] => 10145639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 648651 [patent_doc_number] => 07115252 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-03 [patent_title] => 'Therapeutic compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/144235 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5290 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/115/07115252.pdf [firstpage_image] =>[orig_patent_app_number] => 10144235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736123 [patent_doc_number] => 20030013758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Substituted dicinnamoylquinides and their use in Augmentation of adenosine function' [patent_app_type] => new [patent_app_number] => 10/143606 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7389 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013758.pdf [firstpage_image] =>[orig_patent_app_number] => 10143606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6721405 [patent_doc_number] => 20030055095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Method of treating or inhibiting neutrophil chemotaxis by administering a mek inhibitor' [patent_app_type] => new [patent_app_number] => 10/144315 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20652 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20030055095.pdf [firstpage_image] =>[orig_patent_app_number] => 10144315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653215 [patent_doc_number] => 20030008860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Treatment of congestive heart failure' [patent_app_type] => new [patent_app_number] => 10/129892 [patent_app_country] => US [patent_app_date] => 2002-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7264 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008860.pdf [firstpage_image] =>[orig_patent_app_number] => 10129892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468106 [patent_doc_number] => 20040167085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Pharmaceutical compositions comprising a hmg-coa reductase inhibitor' [patent_app_type] => new [patent_app_number] => 10/476816 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3110 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167085.pdf [firstpage_image] =>[orig_patent_app_number] => 10476816 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018024 [patent_doc_number] => 06890918 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-10 [patent_title] => 'Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers' [patent_app_type] => utility [patent_app_number] => 10/134651 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4906 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890918.pdf [firstpage_image] =>[orig_patent_app_number] => 10134651 [rel_patent_id] =>[rel_patent_doc_number] =>)